medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2016; 15 (1)


Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation

Unzueta A, Valdez R, Chang Yu-Hui H, Desmarteau YM; Heilman RL, Scott RL, Douglas DD, Rakela J

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 33-40
Archivo PDF: 152.96 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-9.

  2. Moal V, Motte A, Kaba M, Gerolami R, Berland Y, Colson P. Hepatitis E virus serological testing in kidney transplant recipients with elevated liver enzymes in 2007-2011 in southeastern France. Diagn Microbiol Infect Dis 2013; 76: 116-8.

  3. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, Muscari F, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202: 835-44.

  4. Unzueta A, Rakela J. Hepatitis E infection in liver transplant recipients. Liver Transpl 2014; 20(1): 15-24.

  5. Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, et al. Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients. N Engl J Med 2014; 370: 1111-20.

  6. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, Ganzenmueller T, et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012; 12: 3128-33.

  7. Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013; 85: 462-71.

  8. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200: 48-56.

  9. Ivo D, Fausta D, Pardha D, Calistus D, Patrick SK, Michael C. Current epidemiology of hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology 2014; 60: 815-22.

  10. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, Sallusto F, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17: 30-7.

  11. Nelson KE, Kmush B, Labrique AB. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev Anti Infect Ther 2011; 9: 1133-48.

  12. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis e seroprevalence estimates. J Infect Dis 2013; 207: 497-500.

  13. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, Dimitrova Z, Kamili S, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51: e24-e27.

  14. Pas SD, Streefkerk R, Pronk M, de Man RA. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013; 58: 629-34.

  15. Baylis SA, Blumel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, Nubling C, et al. World health organization international standard to harmonize assays for detection of hepatitis e virus RNA. Emerg Infect Dis 2013; 19: 729-35.

  16. Danziger-Isakov L, Kumar D. AST Infectious Diseases Community of Practice. Vaccination in solid organ transplantation. Am J Transplant 2013; 13(Suppl. 4): 311-7.

  17. Wedemeyer H, Pethig K, Wagner D, Flemming P, Oppelt P, Petzold DR, Haverich A, et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998; 66: 1347.

  18. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004; 65: 2335-42.

  19. Carbone M, Mutimer D, Neuberger J. Hepatitis C virus and non liver solid organ transplantation. Transplantation 2013; 95: 779-86.

  20. Fagiuoli S, Minniti F, Pevere S, Farinati F, Burra P, Livi U, Naccarato R, et al. HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant 2001; 20: 718-24.

  21. Faramawi MF, Johnson E, Chen S, Pannala PR. The incidence of hepatitis e virus infection in the general population of the USA. Epidemiol Infect 2011; 139(8): 1145-50.




2020     |     www.medigraphic.com